(NASDAQ:CAPR) NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the "Class Period"), of the important September...
Related Questions
How could the securities fraud lawsuit and potential lead plaintiff status affect CAPR's short‑term stock volatility and liquidity?
What is the expected timeline for resolution or settlement of the lawsuit, and how might it intersect with upcoming earnings releases or financing activities?
Does the involvement of Rosen Law Firm and the $100K loss threshold suggest broader shareholder sentiment that could increase short interest or trigger further sell pressure?